OKUR Projected Dividend Yield
OnKure Therapeutics Inc ( NASDAQ : OKUR )OnKure Therapeutics, Inc., formerly Reneo Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company focused on the discovery and development of precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. Using a structure-based drug design platform, the Co. is building a robust pipeline of tumor-agnostic candidates. Co. is developing OKI-219, a selective PI3K?H1047R inhibitor, as its lead program. OKI-219 is being evaluated in a Phase I clinical trial in solid tumor patients with PI3K?H1047R mutations, including breast cancer. 21 YEAR PERFORMANCE RESULTS |
OKUR Dividend History Detail OKUR Dividend News OKUR Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |